v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Net income (loss) $ 1,165 $ 723 $ 1,316 $ 656 $ 1,888 $ 1,972  
(Income) loss from discontinued operations after income taxes 52   66   54 77  
Depreciation and Amortization         636 597  
Provision for (benefit from) deferred income tax         232 (209)  
Net Periodic Pension and OPEB (benefit) cost, net         (5) 19  
Pension and OPEB Contributions         (1,140) (84)  
Net (gain) loss on sales of property, businesses, consolidated companies, and investments         6 (17)  
Restructuring and asset related charges - net [1] 49   79   141 101  
Other net loss         319 272  
Accounts and notes receivable         (2,416) (2,544)  
Inventories         1,227 1,310  
Accounts Payable         (487) (356)  
Deferred Revenue         (3,187) (2,944)  
Other Assets and Liabilities         (613) 667  
Cash Provided by (Used for) Operating Activities, Continuing Operations         (3,345) (1,139)  
Cash Provided by (Used for) Operating Activities, Discontinued Operations         (12) (23)  
Cash Provided by (Used for) Operating Activities         (3,357) (1,162)  
Capital expenditures         (203) (212)  
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested         1 25  
Payments to Acquire Businesses, Net of Cash Acquired         (43) 0  
Investments in and loans to nonconsolidated affiliates         (6) 0  
Proceeds from Sale and Maturities of Investments         9 62  
Proceeds from (payments for) settlement of net investment hedge         0 (56)  
Other investing activities - net         (5) (17)  
Cash provided by (used for) investing activities         (247) (198)  
Net change in borrowings (less than 90 days)         2,398 28  
Proceeds from debt         868 1,214  
Payments on Debt         (989) (335)  
Repurchase of Common Stock         (500) (520)  
Proceeds from Exercise of Stock Options         31 70  
Dividends paid to stockholders         (241) (232)  
Other financing activities, net         (37) (38)  
Cash provided by (used for) financing activities         1,530 187  
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash Equivalents         (32) 68  
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash         (2,106) (1,105)  
Cash, Cash Equivalents and Restricted Cash Equivalents at Beginning of Period   4,725   3,422 4,725 3,422 $ 3,422
Cash, Cash Equivalents and Restricted Cash Equivalents at End of Period 2,619 [2]   2,317 [2]   2,619 [2] 2,317 [2] 4,725
EIDP              
Net income (loss) 1,165 723 1,316 656 1,888 1,972  
(Income) loss from discontinued operations after income taxes 52   66   54 77  
Depreciation and Amortization         636 597  
Provision for (benefit from) deferred income tax         232 (209)  
Net Periodic Pension and OPEB (benefit) cost, net         (5) 19  
Pension and OPEB Contributions         (1,140) (84)  
Net (gain) loss on sales of property, businesses, consolidated companies, and investments         6 (17)  
Restructuring and asset related charges - net 49   79   141 101  
Other net loss         319 272  
Accounts and notes receivable         (2,416) (2,544)  
Inventories         1,227 1,310  
Accounts Payable         (487) (356)  
Deferred Revenue         (3,187) (2,944)  
Other Assets and Liabilities         (613) 667  
Cash Provided by (Used for) Operating Activities, Continuing Operations         (3,345) (1,139)  
Cash Provided by (Used for) Operating Activities, Discontinued Operations         (12) (23)  
Cash Provided by (Used for) Operating Activities         (3,357) (1,162)  
Capital expenditures         (203) (212)  
Proceeds from sales of property, businesses, and consolidated companies - net of cash divested         1 25  
Payments to Acquire Businesses, Net of Cash Acquired         (43) 0  
Investments in and loans to nonconsolidated affiliates         (6) 0  
Proceeds from Sale and Maturities of Investments         9 62  
Proceeds from (payments for) settlement of net investment hedge         0 (56)  
Other investing activities - net         (5) (17)  
Cash provided by (used for) investing activities         (247) (198)  
Net change in borrowings (less than 90 days)         2,398 28  
Net payments from (advances to) Parent on in-house banking arrangement         (9)    
Net payments from (advances to) Parent on in-house banking arrangement           129  
Proceeds from debt         868 1,214  
Payments on Debt         (989) (335)  
Proceeds from Exercise of Stock Options         31 70  
Other financing activities, net         (28) (31)  
Cash provided by (used for) financing activities         1,530 187  
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash Equivalents         (32) 68  
Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash         (2,106) (1,105)  
Cash, Cash Equivalents and Restricted Cash Equivalents at Beginning of Period   $ 4,725   $ 3,422 4,725 3,422 3,422
Cash, Cash Equivalents and Restricted Cash Equivalents at End of Period 2,619   2,317   2,619 2,317 $ 4,725
EIDP | Corteva [Member]              
Dividends paid to stockholders $ (370)   $ (375)   $ (741) $ (888)  
[1] Includes restructuring plans and asset related charges. See Note 4 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information.
[2] See Note 5 - Supplementary Information, to the interim Consolidated Financial Statements, for reconciliation of cash and cash equivalents and restricted cash equivalents presented in the interim Consolidated Balance Sheets to total cash, cash equivalents and restricted cash equivalents presented in the interim Consolidated Statements of Cash Flows.